Over the past 20 years, advances in tumor staging, tumor biology, and therapeutic management have positively influenced both cure rates and overall survival of patients with bladder cancer. Treatment recommendations depend on the stage of the disease, the grade of tumor, likelihood of recurrence, and the patient's medical condition. These patients continue to be faced with treatment options that affect their physical, sexual, and psychosocial well-being.